Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Nemaura , EVERSANA sign agreement for launch of BEATdiabetes in U.S. » 08:03
09/27/22
09/27
08:03
09/27/22
08:03
NMRD

Nemaura Medical

$1.53 /

-0.005 (-0.33%)

Nemaura Medical announces…

Nemaura Medical announces that it has entered into a preliminary agreement with EVERSANA, a pioneer of next-generation commercial services to the global life sciences industry. The agreement covers the U.S. and all global sales and marketing of Nemaura's Diabetes Management Solution, BEATdiabetes. The BEATdiabetes program is based on Nemaura's noninvasive glucose monitoring solution, proBEAT. Nemaura and EVERSANA will work together to develop the optimal launch strategy for large-scale adoption of the diabetes management program including franchising and direct sales to self-insured corporate clients and healthcare insurers. Dr. Faz Chowdhury, Nemaura Medical's Chief Executive Officer, stated, "We are excited to be working with EVERSANA to bring our diabetes management solution to market. This is a culmination of several months of negotiations with EVERSANA following the encouraging outcome of the pilot studies. Diabetes management is an area of huge unmet need, and we anticipate that our solution will be very easy, simple to administer, and highly cost-effective, all elements supporting large-scale adoption."

ShowHide Related Items >><<
NMRD Nemaura Medical
$1.53 /

-0.005 (-0.33%)

NMRD Nemaura Medical
$1.53 /

-0.005 (-0.33%)

08/19/22 H.C. Wainwright
Nemaura Medical price target lowered to $8 from $12 at H.C. Wainwright
03/29/22 H.C. Wainwright
Nemaura Medical initiated with a Buy at H.C. Wainwright
NMRD Nemaura Medical
$1.53 /

-0.005 (-0.33%)

NMRD Nemaura Medical
$1.53 /

-0.005 (-0.33%)

Over a month ago
Recommendations
Nemaura Medical price target lowered to $8 from $12 at H.C. Wainwright » 06:09
08/19/22
08/19
06:09
08/19/22
06:09
NMRD

Nemaura Medical

$2.18 /

-0.04 (-1.80%)

H.C. Wainwright analyst…

H.C. Wainwright analyst Yi Chen lowered the firm's price target on Nemaura Medical to $8 from $12 and keeps a Buy rating on the shares. For fiscal Q1, no revenue was recognized, missing Wainwright's projected sales of $500,000, Chen tells investors in a research note.

ShowHide Related Items >><<
NMRD Nemaura Medical
$2.18 /

-0.04 (-1.80%)

NMRD Nemaura Medical
$2.18 /

-0.04 (-1.80%)

03/29/22 H.C. Wainwright
Nemaura Medical initiated with a Buy at H.C. Wainwright
NMRD Nemaura Medical
$2.18 /

-0.04 (-1.80%)

NMRD Nemaura Medical
$2.18 /

-0.04 (-1.80%)

Earnings
Nemaura Medical reports Q1 EPS (17c) vs (14c) last year » 08:33
08/15/22
08/15
08:33
08/15/22
08:33
NMRD

Nemaura Medical

$2.47 /

+0.04 (+1.65%)

"We are very pleased…

"We are very pleased with the progress we are steadily making with our manufacturing and commercialization support activities. Our daily wearable continuous glucose sensor is unique and innovative, offers lifestyle advantages over competing continuous glucose sensors, and has potential applications for people with diabetes and for the consumer wearable sensor market in general," commented Nemaura CEO Dr. Faz Chowdhury. "We continue to build an outstanding team of scientists, manufacturing personnel, engineers, and commercial managers to help advance the Company to the next phase of maturity and development. Importantly, given the current market climate, we are extremely pleased to have recently raised additional non-dilutive funding without any attached warrants or options, further strengthening our balance sheet as we anticipate growing our revenues in the coming quarters."

ShowHide Related Items >><<
NMRD Nemaura Medical
$2.47 /

+0.04 (+1.65%)

NMRD Nemaura Medical
$2.47 /

+0.04 (+1.65%)

03/29/22 H.C. Wainwright
Nemaura Medical initiated with a Buy at H.C. Wainwright
NMRD Nemaura Medical
$2.47 /

+0.04 (+1.65%)

NMRD Nemaura Medical
$2.47 /

+0.04 (+1.65%)

Hot Stocks
Nemaura Medical granted UK trademark for 'Meta Sore,' a digital biomarker term » 08:18
07/21/22
07/21
08:18
07/21/22
08:18
NMRD

Nemaura Medical

$1.92 /

+0.035 (+1.86%)

Nemaura Medical announced…

Nemaura Medical announced that it has been granted a UK trademark for "Meta Score," a term the Company plans to use as a digital biomarker for its consumer metabolic health program. Trademark applications are now pending in several other major global territories. Meta Score will be the metric and digital biomarker the Company will use as part of its consumer programs. This digital biomarker will derive output from Nemaura's glucose sensor in combination with a number of behavioral inputs of users. "We believe that owning the description of measurement for the biomarker utilized in the Miboko program is an important differentiation among all of the various metabolic health programs currently available," commented Nemaura CEO Faz Chowdhury, Ph.D. "While there are many medical measurements that doctors rely on to understand a person's metabolic health, by creating and branding a simple-to-describe score we have created a means to easily track metabolic health and demonstrate progress while using our sensor that is easy to wear."

ShowHide Related Items >><<
NMRD Nemaura Medical
$1.92 /

+0.035 (+1.86%)

NMRD Nemaura Medical
$1.92 /

+0.035 (+1.86%)

03/29/22 H.C. Wainwright
Nemaura Medical initiated with a Buy at H.C. Wainwright
NMRD Nemaura Medical
$1.92 /

+0.035 (+1.86%)

NMRD Nemaura Medical
$1.92 /

+0.035 (+1.86%)

Over a quarter ago
On The Fly
What You Missed On Wall Street On Thursday » 16:28
06/30/22
06/30
16:28
06/30/22
16:28
WBA

Walgreens Boots Alliance

$37.91 /

-2.97 (-7.27%)

, PFE

Pfizer

$52.52 /

+1.58 (+3.10%)

, BNTX

BioNTech

$149.08 /

+7.01 (+4.93%)

, STZ

Constellation Brands

$232.96 /

-10.715 (-4.40%)

, STZ.B

Constellation Brands; also tag STZ

$294.70 /

+24.21 (+8.95%)

, UHS

Universal Health

$100.73 /

-6.41 (-5.98%)

, RH

RH

$212.33 /

-25.17 (-10.60%)

, AMD

AMD

$76.49 /

-1.52 (-1.95%)

, POSH

Poshmark

$10.13 /

-0.635 (-5.90%)

, SSTI

ShotSpotter

$26.95 /

+1.025 (+3.95%)

, SAP

SAP

$90.75 /

-3.19 (-3.40%)

, VTR

Ventas

$51.43 /

+0.275 (+0.54%)

, CCI

Crown Castle

$168.32 /

+0.9 (+0.54%)

, EQIX

Equinix

$657.35 /

+7.68 (+1.18%)

, DLR

Digital Realty

$129.80 /

+2.15 (+1.68%)

, AKR

Acadia Realty Trust

$15.60 /

-0.26 (-1.64%)

, BRX

Brixmor

$20.21 /

-0.43 (-2.08%)

, KRG

Kite Realty Group

$17.30 /

-0.675 (-3.76%)

, OHI

Omega Healthcare

$28.19 /

-0.935 (-3.21%)

, SBRA

Sabra Health Care

$13.97 /

-0.67 (-4.58%)

, RPT

RPT Realty

$9.83 /

-0.315 (-3.11%)

, SPG

Simon Property

$94.96 /

-2.27 (-2.33%)

, HIW

Highwoods Properties

$34.18 /

-0.62 (-1.78%)

, NVS

Novartis

$84.51 /

-0.35 (-0.41%)

, XRX

Xerox

$14.85 /

-0.22 (-1.46%)

, KHC

Kraft Heinz

$38.14 /

+0.16 (+0.42%)

, TSCDY

Tesco

$9.29 /

-0.0601 (-0.64%)

, COIN

Coinbase

$47.00 /

-2.745 (-5.52%)

, CMCSA

Comcast

$39.24 /

-0.08 (-0.20%)

, CMCSK

Comcast

$58.00 /

+ (+0.00%)

, FIGS

Figs

$9.10 /

+0.8 (+9.64%)

, SAVE

Spirit Airlines

$23.85 /

+1.44 (+6.43%)

, JBLU

JetBlue

$8.38 /

-0.58 (-6.48%)

, ULCC

Frontier Group

$9.35 /

-0.155 (-1.63%)

, SGH

SGH

$16.36 /

-3.94 (-19.41%)

, META

Meta Platforms

$161.27 /

-2.67 (-1.63%)

, AYI

Acuity Brands

$153.99 /

-1.8 (-1.16%)

, POWW

AMMO

$3.85 /

-0.225 (-5.52%)

, DCT

Duck Creek Technologies

$14.79 /

-3.64 (-19.75%)

, CULP

Culp, Inc.

$4.29 /

-0.77 (-15.22%)

, NMRD

Nemaura Medical

$2.59 /

-0.145 (-5.31%)

, MLKN

MillerKnoll

$26.25 /

-1.765 (-6.30%)

Get caught up quickly on…

ShowHide Related Items >><<
XRX Xerox
$14.85 /

-0.22 (-1.46%)

WBA Walgreens Boots Alliance
$37.91 /

-2.97 (-7.27%)

VTR Ventas
$51.43 /

+0.275 (+0.54%)

UHS Universal Health
$100.73 /

-6.41 (-5.98%)

STZ.B Constellation Brands; also tag STZ
$294.70 /

+24.21 (+8.95%)

STZ Constellation Brands
$232.96 /

-10.715 (-4.40%)

SPG Simon Property
$94.96 /

-2.27 (-2.33%)

SGH SGH
$16.36 /

-3.94 (-19.41%)

SBRA Sabra Health Care
$13.97 /

-0.67 (-4.58%)

SAVE Spirit Airlines
$23.85 /

+1.44 (+6.43%)

SAP SAP
$90.75 /

-3.19 (-3.40%)

RPT RPT Realty
$9.83 /

-0.315 (-3.11%)

RH RH
$212.33 /

-25.17 (-10.60%)

POWW AMMO
$3.85 /

-0.225 (-5.52%)

POSH Poshmark
$10.13 /

-0.635 (-5.90%)

PFE Pfizer
$52.52 /

+1.58 (+3.10%)

OHI Omega Healthcare
$28.19 /

-0.935 (-3.21%)

NVS Novartis
$84.51 /

-0.35 (-0.41%)

NMRD Nemaura Medical
$2.59 /

-0.145 (-5.31%)

MLKN MillerKnoll
$26.25 /

-1.765 (-6.30%)

META Meta Platforms
$161.27 /

-2.67 (-1.63%)

KRG Kite Realty Group
$17.30 /

-0.675 (-3.76%)

KHC Kraft Heinz
$38.14 /

+0.16 (+0.42%)

HIW Highwoods Properties
$34.18 /

-0.62 (-1.78%)

FIGS Figs
$9.10 /

+0.8 (+9.64%)

EQIX Equinix
$657.35 /

+7.68 (+1.18%)

DLR Digital Realty
$129.80 /

+2.15 (+1.68%)

DCT Duck Creek Technologies
$14.79 /

-3.64 (-19.75%)

CULP Culp, Inc.
$4.29 /

-0.77 (-15.22%)

COIN Coinbase
$47.00 /

-2.745 (-5.52%)

CMCSK Comcast
$58.00 /

+ (+0.00%)

CMCSA Comcast
$39.24 /

-0.08 (-0.20%)

CCI Crown Castle
$168.32 /

+0.9 (+0.54%)

BRX Brixmor
$20.21 /

-0.43 (-2.08%)

BNTX BioNTech
$149.08 /

+7.01 (+4.93%)

AYI Acuity Brands
$153.99 /

-1.8 (-1.16%)

AMD AMD
$76.49 /

-1.52 (-1.95%)

AKR Acadia Realty Trust
$15.60 /

-0.26 (-1.64%)

WBA Walgreens Boots Alliance
$37.91 /

-2.97 (-7.27%)

07/01/22 Morgan Stanley
Walgreens consensus needs to come down by more than 11%, says Morgan Stanley
07/01/22 Credit Suisse
Walgreens Boots Alliance price target lowered to $43 from $52 at Credit Suisse
07/01/22 Deutsche Bank
Walgreens Boots Alliance price target lowered to $44 from $46 at Deutsche Bank
07/01/22 Truist
Walgreens Boots Alliance price target lowered to $42 from $50 at Truist
PFE Pfizer
$52.52 /

+1.58 (+3.10%)

06/29/22 Evercore ISI
Icosavax upgraded to Outperform at Evercore on 'competitive' RSV vaccine data
06/22/22 Piper Sandler
Enanta's lawsuit against Pfizer 'not surprising,' says Piper Sandler
06/13/22 Morgan Stanley
Moderna pediatric EUA vaccine briefing docs 'clean,' says Morgan Stanley
06/03/22 Oppenheimer
Turning Point Therapeutics downgraded to Perform from Outperform at Oppenheimer
BNTX BioNTech
$149.08 /

+7.01 (+4.93%)

04/12/22 H.C. Wainwright
BioNTech price target lowered to $298 from $339 at H.C. Wainwright
04/11/22 H.C. Wainwright
H.C. Wainwright bullish on Matinas as LNC platform attracts BioNTech collab
04/05/22 Canaccord
BioNTech price target lowered to $300 from $450 at Canaccord
STZ Constellation Brands
$232.96 /

-10.715 (-4.40%)

07/01/22 Credit Suisse
Constellation Brands price target lowered to $292 from $295 at Credit Suisse
07/01/22 Deutsche Bank
Constellation Brands price target lowered to $240 from $248 at Deutsche Bank
06/28/22 Goldman Sachs
Constellation Brands to beat sales estimates in Q1, says Goldman Sachs
06/28/22 Goldman Sachs
Boston Beer downgraded to Sell from Neutral at Goldman Sachs
STZ.B Constellation Brands; also tag STZ
$294.70 /

+24.21 (+8.95%)

05/18/22 Bernstein
Bernstein upgrades Monster Beverage to Outperform, raises price target to $110
01/04/22 Wells Fargo
Constellation Brands price target raised to $300 from $265 at Wells Fargo
UHS Universal Health
$100.73 /

-6.41 (-5.98%)

07/01/22 Mizuho
Universal Health price target lowered to $121 from $153 at Mizuho
06/16/22 Loop Capital
Loop starts Universal Health at Hold on behavioral health staffing concerns
06/16/22 Loop Capital
Universal Health initiated with a Hold at Loop Capital
05/03/22 Mizuho
Universal Health price target lowered to $153 from $164 at Mizuho
RH RH
$212.33 /

-25.17 (-10.60%)

07/01/22 Citi
RH shares offer 'significantly more upside than downside,' says Citi
06/30/22 Morgan Stanley
RH price target lowered to $350 from $385 at Morgan Stanley
06/30/22 Jefferies
RH price target lowered to $400 from $520 at Jefferies
06/30/22 Wedbush
RH price target lowered to $274 from $315 at Wedbush
AMD AMD
$76.49 /

-1.52 (-1.95%)

06/30/22 Northland
AMD upgraded to Outperform at Northland following multiple compression
06/30/22 Northland
AMD upgraded to Outperform from Market Perform at Northland
06/29/22 BofA
AMD price target lowered to $110 from $160 at BofA
06/22/22 Morgan Stanley
AMD resumed with an Overweight at Morgan Stanley
POSH Poshmark
$10.13 /

-0.635 (-5.90%)

06/29/22 Raymond James
Poshmark downgraded to Market Perform from Outperform at Raymond James
06/28/22 Stifel
Poshmark price target raised to $13 from $12 at Stifel
06/09/22 Goldman Sachs
Poshmark price target lowered to $12 from $14 at Goldman Sachs
06/01/22 JMP Securities
Poshmark resumed with Market Perform from Outperform at JMP Securities
SSTI ShotSpotter
$26.95 /

+1.025 (+3.95%)

06/30/22 William Blair
William Blair upgrades ShotSpotter with 60% upside over two years
06/30/22 William Blair
ShotSpotter upgraded to Outperform from Market Perform at William Blair
02/23/22 Lake Street
ShotSpotter price target lowered to $29 from $42 at Lake Street
12/21/21 JMP Securities
ShotSpotter resumed with a Market Perform at JMP Securities
SAP SAP
$90.75 /

-3.19 (-3.40%)

07/01/22 Credit Suisse
SAP remains top pick in European software at Credit Suisse
06/30/22 Exane BNP Paribas
SAP downgraded to Neutral on near-term risks at BNP Paribas
06/30/22 Exane BNP Paribas
SAP downgraded to Neutral from Outperform at Exane BNP Paribas
06/20/22 Jefferies
SAP price target lowered to EUR 110 from EUR 120 at Jefferies
VTR Ventas
$51.43 /

+0.275 (+0.54%)

07/01/22 Mizuho
Ventas price target lowered to $61 from $65 at Mizuho
06/30/22 Jefferies
Ventas upgraded to Buy from Hold at Jefferies
06/22/22 Credit Suisse
Ventas initiated with an Outperform at Credit Suisse
06/03/22 Capital One
Ventas reinstated with Overweight from Equalweight at Capital One
CCI Crown Castle
$168.32 /

+0.9 (+0.54%)

06/30/22 Jefferies
Crown Castle upgraded to Buy from Hold at Jefferies
06/28/22 Deutsche Bank
Crown Castle downgraded to Hold from Buy at Deutsche Bank
06/02/22 Wells Fargo
Wells Fargo cuts Crown Castle to Underweight as growth gap versus peers widens
06/02/22 Wells Fargo
Crown Castle downgraded to Underweight from Equal Weight at Wells Fargo
EQIX Equinix
$657.35 /

+7.68 (+1.18%)

07/01/22 Wells Fargo
Chanos' argument on data centers 'unoriginal' and 'misguided,' says Wells Fargo
06/30/22 Jefferies
Equinix upgraded to Buy from Hold at Jefferies
06/30/22 JPMorgan
JPMorgan remains positive on data center industry after short call
06/29/22 Cowen
Cowen 'largely disagrees' with Chanos' short thesis on data centers
DLR Digital Realty
$129.80 /

+2.15 (+1.68%)

06/30/22 Jefferies
Digital Realty upgraded to Buy from Hold at Jefferies
AKR Acadia Realty Trust
$15.60 /

-0.26 (-1.64%)

06/30/22 Jefferies
Acadia Realty Trust downgraded to Hold at Jefferies among REIT rating shake-up
06/30/22 Jefferies
Acadia Realty Trust downgraded to Hold from Buy at Jefferies
06/22/22 Compass Point
Acadia Realty Trust price target lowered to $23 from $25 at Compass Point
06/21/22 Truist
Acadia Realty Trust price target lowered to $23 from $27 at Truist
BRX Brixmor
$20.21 /

-0.43 (-2.08%)

06/30/22 Jefferies
Brixmor downgraded to Underperform from Hold at Jefferies
06/22/22 Credit Suisse
Brixmor initiated with an Outperform at Credit Suisse
06/22/22 JPMorgan
Brixmor upgraded to Overweight from Neutral at JPMorgan
06/21/22 Truist
Brixmor price target lowered to $26 from $29 at Truist
KRG Kite Realty Group
$17.30 /

-0.675 (-3.76%)

06/30/22 Jefferies
Kite Realty Group downgraded to Hold from Buy at Jefferies
06/22/22 Compass Point
Kite Realty Group price target lowered to $27 from $30 at Compass Point
01/13/22 Baird
Kite Realty Group upgraded to Outperform from Neutral at Baird
10/27/21 Jefferies
Kite Realty Group initiated with a Buy at Jefferies
OHI Omega Healthcare
$28.19 /

-0.935 (-3.21%)

06/30/22 Jefferies
Omega Healthcare downgraded to Hold from Buy at Jefferies
06/14/22 Truist
Omega Healthcare price target lowered to $30 from $33 at Truist
06/03/22 Capital One
Omega Healthcare reinstated with an Equalweight at Capital One
04/26/22 Barclays
Omega Healthcare initiated with an Equal Weight at Barclays
SBRA Sabra Health Care
$13.97 /

-0.67 (-4.58%)

06/30/22 Jefferies
Sabra Health Care downgraded to Hold from Buy at Jefferies
06/03/22 Capital One
Sabra Health Care reinstated with an Equalweight at Capital One
05/25/22 Mizuho
Sabra Health Care upgraded to Buy from Neutral at Mizuho
RPT RPT Realty
$9.83 /

-0.315 (-3.11%)

06/30/22 Jefferies
RPT Realty downgraded to Hold from Buy at Jefferies
06/22/22 Credit Suisse
RPT Realty initiated with an Outperform at Credit Suisse
10/14/21 Mizuho
RPT Realty initiated with a Buy at Mizuho
10/06/21 Deutsche Bank
RPT Realty price target lowered to $16 from $17 at Deutsche Bank
SPG Simon Property
$94.96 /

-2.27 (-2.33%)

06/30/22 Jefferies
Simon Property downgraded to Hold at Jefferies among REIT rating shake-up
06/30/22 Jefferies
Simon Property downgraded to Hold from Buy at Jefferies
06/22/22 Compass Point
Simon Property price target lowered to $160 from $200 at Compass Point
06/03/22 Truist
Simon Property price target lowered to $130 from $155 at Truist
HIW Highwoods Properties
$34.18 /

-0.62 (-1.78%)

06/30/22 Jefferies
Highwoods Properties downgraded to Hold from Buy at Jefferies
06/30/22 Truist
Highwoods Properties price target lowered to $42 from $48 at Truist
06/22/22 Credit Suisse
Highwoods Properties initiated with a Neutral at Credit Suisse
04/22/22 Mizuho
Highwoods Properties initiated with a Neutral at Mizuho
NVS Novartis
$84.51 /

-0.35 (-0.41%)

06/29/22 Deutsche Bank
Novartis price target lowered to CHF 75 from CHF 80 at Deutsche Bank
05/13/22 Piper Sandler
Point Biopharma price target lowered to $14 from $17 at Piper Sandler
05/13/22 Jefferies
Roche downgraded to Hold from Buy at Jefferies
XRX Xerox
$14.85 /

-0.22 (-1.46%)

04/22/22 Citi
Xerox price target lowered to $15 from $17 at Citi
02/24/22 Gordon Haskett
Icahn could take Xerox private 'without breaking a sweat,' says Gordon Haskett
11/23/21 Gordon Haskett
Gordon Haskett highlights Tyson, Xerox after Ericsson-Vonage deal
07/02/21 Bernstein
HP plus Xerox 'consolidation math compelling,' says Bernstein
KHC Kraft Heinz
$38.14 /

+0.16 (+0.42%)

06/22/22 BMO Capital
Kraft Heinz upgraded to Outperform from Market Perform at BMO Capital
05/26/22 UBS
UBS cuts Kraft Heinz to Sell, sees private label trade-down risk not priced in
05/26/22 UBS
Kraft Heinz downgraded to Sell from Neutral at UBS
05/09/22 BofA
Coca-Cola, Kraft Heinz added to 'US 1' list at BofA
TSCDY Tesco
$9.29 /

-0.0601 (-0.64%)

04/19/22 Berenberg
Tesco price target lowered to 320 GBp from 327 GBp at Berenberg
10/20/21 Berenberg
Tesco price target raised to 308 GBp from 280 GBp at Berenberg
10/13/21 Morgan Stanley
Tesco price target raised to 318 GBp from 303 GBp at Morgan Stanley
10/07/21 JPMorgan
Tesco price target raised to 330 GBp from 300 GBp at JPMorgan
COIN Coinbase
$47.00 /

-2.745 (-5.52%)

06/27/22 Goldman Sachs
Coinbase downgraded to Sell from Neutral at Goldman Sachs
06/23/22 Redburn
Coinbase downgraded to Neutral from Buy at Redburn
06/22/22 BTIG
Coinbase price target lowered to $290 from $380 at BTIG
06/22/22 Mizuho
Coinbase trading patterns show potential 'crypto fatigue,' says Mizuho
CMCSA Comcast
$39.24 /

-0.08 (-0.20%)

07/01/22 Daiwa
Comcast initiated with an Outperform at Daiwa
06/29/22 TD Securities
Comcast price target lowered to $60 from $65 at TD Securities
06/28/22 Scotiabank
Comcast assumed with an Outperform at Scotiabank (yesterday)
06/21/22 Truist
Magnite well positioned to partner with Netflix, says Truist
CMCSK Comcast
$58.00 /

+ (+0.00%)

05/23/22 Raymond James
Electronic Arts moves 'somewhat unexpected,' says Raymond James
04/14/22 Oppenheimer
Comcast price target lowered to $60 from $75 at Oppenheimer
03/23/22 Craig-Hallum
ComScore poised for share gains in local measurement, says Craig-Hallum
FIGS Figs
$9.10 /

+0.8 (+9.64%)

06/29/22 Raymond James
Figs initiated with a Strong Buy at Raymond James
05/16/22 Barclays
Figs price target lowered to $13 from $34 at Barclays
05/16/22 Oppenheimer
Figs price target lowered to $22 from $45 at Oppenheimer
05/16/22 BofA
Figs downgraded to Neutral from Buy at BofA
SAVE Spirit Airlines
$23.85 /

+1.44 (+6.43%)

06/27/22 Evercore ISI
Spirit Airlines price target raised to $28 from $25 at Evercore ISI
06/23/22 Raymond James
Frontier Group upgraded to Outperform from Market Perform at Raymond James
06/10/22 JPMorgan
Spirit Airlines upgraded to Overweight from Neutral at JPMorgan
05/05/22 Deutsche Bank
Spirit Airlines price target lowered to $27 from $38 at Deutsche Bank
JBLU JetBlue
$8.38 /

-0.58 (-6.48%)

06/27/22 Evercore ISI
JetBlue price target lowered to $10 from $13 at Evercore ISI
04/26/22 JPMorgan
JetBlue double downgraded to Underweight from Overweight at JPMorgan
ULCC Frontier Group
$9.35 /

-0.155 (-1.63%)

06/27/22 Evercore ISI
Frontier Group price target lowered to $15 from $20 at Evercore ISI
04/11/22 MKM Partners
JetBlue upgraded to Neutral at MKM Partners on valuation
SGH SGH
$16.36 /

-3.94 (-19.41%)

06/30/22 Needham
SGH price target lowered to $40 from $45 at Needham
06/30/22 Stifel
SGH price target lowered to $32 from $45 at Stifel
06/30/22 Deutsche Bank
SGH price target lowered to $32 from $40 at Deutsche Bank
06/30/22 Barclays
SGH price target lowered to $22 from $30 at Barclays
META Meta Platforms
$161.27 /

-2.67 (-1.63%)

06/30/22 JMP Securities
Meta Platforms price target lowered to $240 from $265 at JMP Securities
06/29/22 JPMorgan
Meta Platforms price target lowered to $225 from $275 at JPMorgan
06/22/22 BofA
Meta's Creator commission delay impacts 2023 revenue less than 1%, says BofA
06/16/22 Truist
France ruling on Meta incremental positive for Criteo, says Truist
AYI Acuity Brands
$153.99 /

-1.8 (-1.16%)

07/01/22 Oppenheimer
Acuity Brands delivers 'strong organic beat' in Q3, says Oppenheimer
07/01/22 Baird
Acuity Brands price target raised to $190 from $188 at Baird
06/27/22 Credit Suisse
Acuity Brands price target lowered to $211 from $241 at Credit Suisse
06/23/22 William Blair
William Blair downgrades Acuity Brands after survey points to weaker demand
POWW AMMO
$3.85 /

-0.225 (-5.52%)

06/30/22 EF Hutton
AMMO shares should be bought 'aggressively,' says EF Hutton
08/17/21 Lake Street
AMMO price target raised to $12 at Lake Street after beat and raise report
DCT Duck Creek Technologies
$14.79 /

-3.64 (-19.75%)

07/01/22 JMP Securities
Duck Creek downgraded to Market Perform from Outperform at JMP Securities
06/30/22 BofA
Duck Creek Technologies downgraded to Neutral from Buy at BofA
06/30/22 BofA
Duck Creek Technologies downgraded to Neutral from Buy at BofA
06/30/22 RBC Capital
Duck Creek Technologies price target lowered to $18 from $25 at RBC Capital
CULP Culp, Inc.
$4.29 /

-0.77 (-15.22%)

NMRD Nemaura Medical
$2.59 /

-0.145 (-5.31%)

03/29/22 H.C. Wainwright
Nemaura Medical initiated with a Buy at H.C. Wainwright
07/12/21 Ascendiant
Nemaura Medical price target raised to $17 from $15 at Ascendiant
MLKN MillerKnoll
$26.25 /

-1.765 (-6.30%)

06/30/22 Craig-Hallum
MillerKnoll price target lowered to $50 from $60 at Craig-Hallum
XRX Xerox
$14.85 /

-0.22 (-1.46%)

WBA Walgreens Boots Alliance
$37.91 /

-2.97 (-7.27%)

VTR Ventas
$51.43 /

+0.275 (+0.54%)

ULCC Frontier Group
$9.35 /

-0.155 (-1.63%)

UHS Universal Health
$100.73 /

-6.41 (-5.98%)

STZ Constellation Brands
$232.96 /

-10.715 (-4.40%)

SSTI ShotSpotter
$26.95 /

+1.025 (+3.95%)

SPG Simon Property
$94.96 /

-2.27 (-2.33%)

SGH SGH
$16.36 /

-3.94 (-19.41%)

SBRA Sabra Health Care
$13.97 /

-0.67 (-4.58%)

SAVE Spirit Airlines
$23.85 /

+1.44 (+6.43%)

SAP SAP
$90.75 /

-3.19 (-3.40%)

RH RH
$212.33 /

-25.17 (-10.60%)

POWW AMMO
$3.85 /

-0.225 (-5.52%)

POSH Poshmark
$10.13 /

-0.635 (-5.90%)

PFE Pfizer
$52.52 /

+1.58 (+3.10%)

OHI Omega Healthcare
$28.19 /

-0.935 (-3.21%)

NVS Novartis
$84.51 /

-0.35 (-0.41%)

NMRD Nemaura Medical
$2.59 /

-0.145 (-5.31%)

MLKN MillerKnoll
$26.25 /

-1.765 (-6.30%)

KRG Kite Realty Group
$17.30 /

-0.675 (-3.76%)

KHC Kraft Heinz
$38.14 /

+0.16 (+0.42%)

JBLU JetBlue
$8.38 /

-0.58 (-6.48%)

FIGS Figs
$9.10 /

+0.8 (+9.64%)

EQIX Equinix
$657.35 /

+7.68 (+1.18%)

DLR Digital Realty
$129.80 /

+2.15 (+1.68%)

DCT Duck Creek Technologies
$14.79 /

-3.64 (-19.75%)

CULP Culp, Inc.
$4.29 /

-0.77 (-15.22%)

COIN Coinbase
$47.00 /

-2.745 (-5.52%)

CMCSA Comcast
$39.24 /

-0.08 (-0.20%)

CCI Crown Castle
$168.32 /

+0.9 (+0.54%)

BRX Brixmor
$20.21 /

-0.43 (-2.08%)

BNTX BioNTech
$149.08 /

+7.01 (+4.93%)

AYI Acuity Brands
$153.99 /

-1.8 (-1.16%)

AMD AMD
$76.49 /

-1.52 (-1.95%)

AKR Acadia Realty Trust
$15.60 /

-0.26 (-1.64%)

  • 18
    Nov
  • 13
    Oct
  • 16
    Sep
  • 09
    Sep
XRX Xerox
$14.85 /

-0.22 (-1.46%)

WBA Walgreens Boots Alliance
$37.91 /

-2.97 (-7.27%)

ULCC Frontier Group
$9.35 /

-0.155 (-1.63%)

UHS Universal Health
$100.73 /

-6.41 (-5.98%)

STZ Constellation Brands
$232.96 /

-10.715 (-4.40%)

SPG Simon Property
$94.96 /

-2.27 (-2.33%)

SAVE Spirit Airlines
$23.85 /

+1.44 (+6.43%)

SAP SAP
$90.75 /

-3.19 (-3.40%)

RH RH
$212.33 /

-25.17 (-10.60%)

POSH Poshmark
$10.13 /

-0.635 (-5.90%)

PFE Pfizer
$52.52 /

+1.58 (+3.10%)

NVS Novartis
$84.51 /

-0.35 (-0.41%)

META Meta Platforms
$161.27 /

-2.67 (-1.63%)

KHC Kraft Heinz
$38.14 /

+0.16 (+0.42%)

FIGS Figs
$9.10 /

+0.8 (+9.64%)

EQIX Equinix
$657.35 /

+7.68 (+1.18%)

COIN Coinbase
$47.00 /

-2.745 (-5.52%)

CMCSK Comcast
$58.00 /

+ (+0.00%)

CMCSA Comcast
$39.24 /

-0.08 (-0.20%)

AMD AMD
$76.49 /

-1.52 (-1.95%)

XRX Xerox
$14.85 /

-0.22 (-1.46%)

WBA Walgreens Boots Alliance
$37.91 /

-2.97 (-7.27%)

VTR Ventas
$51.43 /

+0.275 (+0.54%)

UHS Universal Health
$100.73 /

-6.41 (-5.98%)

STZ.B Constellation Brands; also tag STZ
$294.70 /

+24.21 (+8.95%)

STZ Constellation Brands
$232.96 /

-10.715 (-4.40%)

SPG Simon Property
$94.96 /

-2.27 (-2.33%)

SBRA Sabra Health Care
$13.97 /

-0.67 (-4.58%)

SAVE Spirit Airlines
$23.85 /

+1.44 (+6.43%)

SAP SAP
$90.75 /

-3.19 (-3.40%)

RH RH
$212.33 /

-25.17 (-10.60%)

POSH Poshmark
$10.13 /

-0.635 (-5.90%)

PFE Pfizer
$52.52 /

+1.58 (+3.10%)

OHI Omega Healthcare
$28.19 /

-0.935 (-3.21%)

NVS Novartis
$84.51 /

-0.35 (-0.41%)

MLKN MillerKnoll
$26.25 /

-1.765 (-6.30%)

META Meta Platforms
$161.27 /

-2.67 (-1.63%)

KHC Kraft Heinz
$38.14 /

+0.16 (+0.42%)

COIN Coinbase
$47.00 /

-2.745 (-5.52%)

CMCSA Comcast
$39.24 /

-0.08 (-0.20%)

CCI Crown Castle
$168.32 /

+0.9 (+0.54%)

AYI Acuity Brands
$153.99 /

-1.8 (-1.16%)

AMD AMD
$76.49 /

-1.52 (-1.95%)

AKR Acadia Realty Trust
$15.60 /

-0.26 (-1.64%)

WBA Walgreens Boots Alliance
$37.91 /

-2.97 (-7.27%)

UHS Universal Health
$100.73 /

-6.41 (-5.98%)

STZ Constellation Brands
$232.96 /

-10.715 (-4.40%)

SSTI ShotSpotter
$26.95 /

+1.025 (+3.95%)

SPG Simon Property
$94.96 /

-2.27 (-2.33%)

SGH SGH
$16.36 /

-3.94 (-19.41%)

SAVE Spirit Airlines
$23.85 /

+1.44 (+6.43%)

SAP SAP
$90.75 /

-3.19 (-3.40%)

RH RH
$212.33 /

-25.17 (-10.60%)

POWW AMMO
$3.85 /

-0.225 (-5.52%)

POSH Poshmark
$10.13 /

-0.635 (-5.90%)

PFE Pfizer
$52.52 /

+1.58 (+3.10%)

META Meta Platforms
$161.27 /

-2.67 (-1.63%)

KHC Kraft Heinz
$38.14 /

+0.16 (+0.42%)

JBLU JetBlue
$8.38 /

-0.58 (-6.48%)

FIGS Figs
$9.10 /

+0.8 (+9.64%)

EQIX Equinix
$657.35 /

+7.68 (+1.18%)

DCT Duck Creek Technologies
$14.79 /

-3.64 (-19.75%)

COIN Coinbase
$47.00 /

-2.745 (-5.52%)

CMCSA Comcast
$39.24 /

-0.08 (-0.20%)

CCI Crown Castle
$168.32 /

+0.9 (+0.54%)

BNTX BioNTech
$149.08 /

+7.01 (+4.93%)

AMD AMD
$76.49 /

-1.52 (-1.95%)

Earnings
Nemaura Medical reports 2022 EPS (59c), consensus (58c) » 08:03
06/30/22
06/30
08:03
06/30/22
08:03
NMRD

Nemaura Medical

$2.73 /

+0.07 (+2.63%)

Reports 2022 revenue…

Reports 2022 revenue $503,906, consensus $500,000. "On the heels of successfully commercializing sugarBEAT in fiscal 2022 and recognizing our first revenue from our UK licensee MySugarWatch Limited, our primary goal in fiscal 2023 is to expand our revenue by supporting the launch effort of MySugarWatch Limited in the UK. We expect additional purchase orders to support the UK launch, as well as the anticipated Duo-Pack launch later in calendar 2022. MySugarWatch Limited has already begun mass advertising through education and awareness campaigns to healthcare professionals and direct to consumers through the national press," commented Dr. Faz Chowdhury, CEO of Nemaura. "Furthermore, we are exploring additional new channels in other territories with our technology platform. We have also started to engage with large scale manufacturers to enable us to meet the strong worldwide diabetic monitoring demand, and any appreciable scale we can build in our business should be meaningful to shareholder value. We look forward to updating investors with additional corporate highlights as they unfold."

ShowHide Related Items >><<
NMRD Nemaura Medical
$2.73 /

+0.07 (+2.63%)

NMRD Nemaura Medical
$2.73 /

+0.07 (+2.63%)

03/29/22 H.C. Wainwright
Nemaura Medical initiated with a Buy at H.C. Wainwright
07/12/21 Ascendiant
Nemaura Medical price target raised to $17 from $15 at Ascendiant
NMRD Nemaura Medical
$2.73 /

+0.07 (+2.63%)

Hot Stocks
Nemaura Medical says MySugarWatch continues sugarBEAT awareness campaign » 08:10
05/17/22
05/17
08:10
05/17/22
08:10
NMRD

Nemaura Medical

$2.61 /

-0.1 (-3.69%)

Nemaura Medical announces…

Nemaura Medical announces that its UK licensee, MySugarWatch, has continued its large scale awareness campaign for the Company's sugarBEAT non-invasive continuous glucose monitor by commencing a direct-to-consumer campaign in one of the UK's largest daily newspaper, Daily Mail. MySugarWatch's Daily Mail campaign is designed to reach its more than 1.2 million daily readers, inviting them to learn more about glucose management as part of sugarBEAT commercialization by Nemaura's UK licensee. The Daily Mail ads are part of a previously announced wider campaign, which also targets media outlets geared toward both consumers and professionals.

ShowHide Related Items >><<
NMRD Nemaura Medical
$2.61 /

-0.1 (-3.69%)

NMRD Nemaura Medical
$2.61 /

-0.1 (-3.69%)

03/29/22 H.C. Wainwright
Nemaura Medical initiated with a Buy at H.C. Wainwright
07/12/21 Ascendiant
Nemaura Medical price target raised to $17 from $15 at Ascendiant
NMRD Nemaura Medical
$2.61 /

-0.1 (-3.69%)

Hot Stocks
MySugarWatch launches physician-focused ads in MIMS » 08:32
05/03/22
05/03
08:32
05/03/22
08:32
NMRD

Nemaura Medical

$3.40 /

-0.16 (-4.49%)

Nemaura Medical announces…

Nemaura Medical announces that its UK licensee, MySugarWatch, as part of a large scale awareness campaign for the Company's sugarBEAT non-invasive continuous glucose monitor, has launched a series of ads in one the UK's preeminent physician and pharmacist education resources, MIMS. MySugarWatch's campaign is targeted to more than 50,000 clinicians as commercialization of sugarBEAT commences. The wider campaign, which also targets a wide variety of media outlets targeting both consumers and professionals, began in April 2022.

ShowHide Related Items >><<
NMRD Nemaura Medical
$3.40 /

-0.16 (-4.49%)

NMRD Nemaura Medical
$3.40 /

-0.16 (-4.49%)

03/29/22 H.C. Wainwright
Nemaura Medical initiated with a Buy at H.C. Wainwright
07/12/21 Ascendiant
Nemaura Medical price target raised to $17 from $15 at Ascendiant
NMRD Nemaura Medical
$3.40 /

-0.16 (-4.49%)

Initiation
Nemaura Medical initiated with a Buy at H.C. Wainwright » 06:12
03/29/22
03/29
06:12
03/29/22
06:12
NMRD

Nemaura Medical

$4.00 /

+0.09 (+2.30%)

H.C. Wainwright analyst…

H.C. Wainwright analyst Yi Chen initiated coverage of Nemaura Medical with a Buy rating and $12 price target. Nemaura is a commercial-stage medical device company focused on the development and commercialization of the first non-invasive, needle-free and flexible continuous glucose monitoring system, sugarBEAT, for adjunctive use by diabetes patients as well as those who wish to determine factors influencing their blood glucose profiles, Chen tells investors in a research note. The analyst says sugarBEAT is differentiated in that it makes glucose come to the skin surface to be harvested and measured.

ShowHide Related Items >><<
NMRD Nemaura Medical
$4.00 /

+0.09 (+2.30%)

NMRD Nemaura Medical
$4.00 /

+0.09 (+2.30%)

07/12/21 Ascendiant
Nemaura Medical price target raised to $17 from $15 at Ascendiant
NMRD Nemaura Medical
$4.00 /

+0.09 (+2.30%)

Syndicate
Nemaura Medical files $224.63M mixed securities shelf  16:55
03/16/22
03/16
16:55
03/16/22
16:55
NMRD

Nemaura Medical

$4.06 /

+ (+0.00%)

 
ShowHide Related Items >><<
NMRD Nemaura Medical
$4.06 /

+ (+0.00%)

NMRD Nemaura Medical
$4.06 /

+ (+0.00%)

07/12/21 Ascendiant
Nemaura Medical price target raised to $17 from $15 at Ascendiant
NMRD Nemaura Medical
$4.06 /

+ (+0.00%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.